Fluence recognizes the need for rigorous training in psychedelic clinical trials to maximize patient safety and generate reliable data. Our services are designed, overseen, and provided by licensed clinicians with experience on the world’s most advanced psychedelic clinical treatment trials.
We’ve worked with a dozen drug developers and multiple compounds, in multilingual and multinational contexts, and are continuing to grow our training program resources.
Custom Learning Management System
Secure, role-based access to training materials for trainees, sponsors, and CROs.
Mobile App Integration
Platform accessibility for trainees to reduce time-to-completion.
Extensive Content Library
Includes introductory lessons, materials on adverse events, ethics, specific molecules, and demonstration videos you can choose from to reduce your production cost and time.
Role-Specific Training Tracks
Tailored programming for clinicians, site staff, sponsor teams, and other stakeholders.
Training Documentation & Compliance
Timestamped, traceable completion records for audit readiness.
Custom demonstration/didactic videos filmed in a dedicated studio with experienced clinicians.
Custom
assessments
Live-in-person training sessions
Live-online training sessions
Feedback sessions
Competency evaluations
Peer Mentoring
Group sessions led by experienced clinicians to sustain adherence during trials.
Educational Consultation
Effective oversight planning ensures that study clinicians have a clear, designated support system in place for when they need additional guidance. Our experienced research therapists provide consultation in a structured, documented manner to support ongoing adherence to your treatment manual and enhance patient safety.
Educational Consultation services can be delivered in coordination with mpathic when sponsors leverage mpathic’s technology to analyze therapist adherence during active clinical trials, using HIPAA-compliant, scientifically validated AI to provide detailed insights into therapist performance. Fluence’s educational consultants then use these insights to deliver precise feedback and guidance. This complementary approach enables Fluence to concentrate on training and skills development, while mpathic provides essential conversation analytics, empowering drug development partners to enhance therapist effectiveness and reliability throughout active trial stages, establishing new standards for psychedelic clinical trials.
Fluence Educational Consultation services are also available as a stand-alone service without AI support.
Reference:
PRWeb
Fluence is revolutionizing psychedelic therapy leveraging generative AI to enhance the training of site staff for clinical trials, providing actionable insights, cost savings, and improved efficiency for our drug development partners.
Automated feedback
The AI tool evaluates provider-patient interactions according to a customized rubric to identify areas for improvement quickly and reliably.
Identify opportunities
If a provider misses a therapeutic opportunity—like changing the subject after a patient shares something emotionally significant—the feedback produced by AI will highlight this in a report.
Increased efficiency
By automating initial assessments, Fluence trainers can focus on key areas of improvement and competency development on short timelines.
This innovative AI tool is being integrated into Fluence’s training programs for healthcare providers involved in clinical trials with leading partners like Reunion Neuroscience and Cybin.
Scalable training
The tool makes large-scale therapist development more feasible, a critical factor for the future of psychedelic treatments post-approval.
Cost savings and efficiency
Automated feedback allows drug development partners to reduce costs and streamline training without sacrificing quality.
Real-world impact
The enhanced training program ensures providers are better prepared to deliver effective psychedelic therapy, improving patient outcomes in clinical trials and beyond.
Innovations in facilitator learning and development are crucial for scalability of psychedelic treatments post-approval, Fluence is demonstrating excellent leadership in exploring and integrating technology-based competency development and assessment tools.
Alex Kelman,
Ph.D., Head of Therapies at Cybin
At Reunion Neuroscience, we are committed to advancing innovative treatments for mental health conditions. Our partnership with Fluence … exemplifies our dedication to leveraging cutting-edge technologies to enhance the quality and scalability of psychedelic therapy. We believe this AI-powered training tool will not only benefit our clinical trials but also contribute to the broader field of psychedelic-assisted therapy, ultimately improving patient outcomes.
Greg Mayes,
CEO of Reunion Neuroscience
Read more about our enterprise solutions:
For more information about Fluence’s innovative training programs and partnerships, contact us.
